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Condensation 
A prediction model is able to predict detrusor overactivity more accurately than a 
symptomatic diagnosis alone, in women with lower urinary tract symptoms. 
 
Abstract 
 
Objective 
Traditionally, urodynamic studies (UDS) have been used to assess lower urinary tract 
symptoms (LUTS), but their routine use is now discouraged. While urodynamic stress 
incontinence is strongly associated with the symptom of stress urinary incontinence (SUI) 
and a positive cough test, there is a weak relationship between symptoms of overactive 
bladder and detrusor overactivity (DO). The aim of our study was to develop a model to 
predict DO in women with LUTS. 
 
Study Design 
This prospective study included consecutive women with LUTS attending a urodynamic 
clinic. All women underwent a comprehensive clinical and urodynamic assessment. The 
effect of each variable on the odds of DO was estimated both by univariate analysis and 
adjusted analysis using logistic regression.  
 
Results 
1006 women with LUTS were included in the study with 374 patients (37%) diagnosed with 
DO. The factors considered to be the best predictors of DO were urgency urinary 
incontinence, urge rating/void and parity (p-value <0.01). The absence of SUI, vaginal 
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bulging and previous continence surgery were also good predictors of DO (p-value < 0.01). 
We have created a prediction model for DO based on our best predictors. In our scoring 
system, presence of UUI scores 5; mean urge rating/void ≥ 3 scores 3; parity ≥ 2 scores 2; 
previous continence surgery scores -1; presence of SUI scores -1; and the complaint of 
vaginal bulging scores -1. If a criterion is absent, then the score is 0 and the total score can 
vary from a value of -3 to +10. The Receiver Operating Characteristic (ROC) analysis for the 
overall cut-off points revealed an area under the curve of 0.748 (95%CI 0.741, 0.755).   
 
Conclusion 
This model is able to predict DO more accurately than a symptomatic diagnosis alone, in 
women with LUTS. The introduction of this scoring system as a screening tool into clinical 
practice may reduce the need for expensive and invasive tests to diagnose DO, but cannot 
replace UDS completely. 
 
 
Keywords 
Detrusor overactivity, lower urinary tract symptoms, prediction model, urinary incontinence, 
urodynamics 
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Text 
 
Introduction  
Lower urinary tract symptoms (LUTS) are common in women with a reported prevalence up 
to 66.6% in large epidemiological studies [1]. They are under-reported and under-treated 
despite their significant adverse effect on quality of life (QoL) [2]. Traditionally, urodynamic 
studies (UDS) have been used to assess LUTS, but their routine use is now questioned. As 
UDS are invasive and expensive tests without evidence-based additional value in the 
management of women with urinary incontinence (UI), their routine use is discouraged by 
international professional bodies [3,4].  
Conventionally, stress urinary incontinence (SUI) is the predominant symptom associated 
with urodynamic stress incontinence (USI) and urgency urinary incontinence (UUI) with the 
urodynamic observation of detrusor overactivity (DO). The correlation between the clinical 
and urodynamic diagnosis in women is weaker than the correlation in the male population 
[5]. Several studies have compared clinical and urodynamic diagnoses of UI in women. A 
recent systematic review showed that the positive predictive value (PPV) of SUI to diagnose 
USI was 75% (range 41-95%), but the PPV of UUI to diagnose DO was only 58% (range 22-
100%) [6]. A combined assessment including history, physical examination and bedside tests 
is less helpful in diagnosing DO compared to USI [7]. 
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Few researchers have attempted to identify clinical predictors of DO. Variables such as the 
maximum urge rating in an urgency scale [8], the presenting bladder volume at urodynamics 
[9] have been proposed as potential predictors. A number of prediction tools have been 
developed to help to diagnose DO, but their use in clinical practice has been limited due to 
the required complex calculations [10,11]. A prediction model combining symptoms, 
examination findings and non-invasive tests such as bladder diaries incorporating urgency 
scales is probably closer to daily clinical practice and is likely to show better agreement with 
UDS. The purpose of this study was to develop a simple prediction model to estimate the risk 
of DO in female patients with LUTS. 
 
Materials and methods 
Participants 
This was a cross-sectional study in a tertiary referral Urogynaecology Unit. Consecutive 
women attending a one-stop urodynamic assessment clinic with LUTS were included in the 
study. Ethical approval was granted by the regional Research Ethics Committee. 
We excluded women unable to read and complete a questionnaire in the English language; 
younger than 18 years; with dementia or memory disorders; with known neurological 
conditions such as stroke, multiple sclerosis, spinal cord injury or Parkinson’s disease; on 
antimuscarinic medication within seven days of the attendance in the clinic; with evidence of 
urinary tract infection on urinalysis (presence of nitrites with or without leucocytes) on the 
day of the appointment.  
 
Procedures 
All women were asked to complete a disease-specific health related quality of life (HRQoL) 
questionnaire (King’s Health Questionnaire, KHQ) [2] and 3-day bladder diary incorporating 
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the validated Patient’s Perception of Intensity of Urgency Scale (PPIUS) [12],  before 
attending the urodynamic clinic. The symptom domain of the KHQ was used to assess the 
presence of LUTS. The five grades of the PPIUS (from 0: no urgency, to 4: urgency 
incontinence) were used to assess the degree of urgency associated with each void. Urgency 
episodes were counted as suggested by Cardozo et al as voids with PPIUS level 3 and 4 
(without or with urgency incontinence respectively) [13]. Daytime urinary frequency, 
nocturnal frequency and the functional bladder capacity were recorded from the bladder 
diary.   
Initial assessment included medical history, physical examination and urinalysis. Pelvic organ 
prolapse was assessed in both the lithotomy position and standing with the patient exerting a 
maximal Valsalva manoeuvre using the pelvic organ prolapse quantification (POPQ) system 
[14]. The participants then underwent multichannel urodynamics according to the ICS 
recommendations [15]. Women, whose symptoms of urgency were not reproduced during the 
laboratory test, underwent a 4-hour ambulatory urodynamics test following a standardised 
protocol [16]. 
 
Statistical analysis 
Analysis of descriptive data was carried out in three ways. Firstly we looked at continuous 
variables and investigated their distribution. If a variable was found to be symmetrical, then 
the mean and standard deviation was used to summarise the variable, otherwise the median 
and interquartile range was used to summarise the variable. To test any differences for 
continuous variables either a parametric or non-parametric test was used depending on 
whether the variable was symmetrical or not. Secondly, we considered nominal categorical 
variables and tabulated the proportions in the DO group and non-DO group and the 
differences were tested by using either the chi-squared test or Fisher’s exact test depending 
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on whether the expected assumptions for chi-squared test were satisfied or not. Thirdly, we 
considered categorical variables with ordinal values. For these variables, proportions were 
analysed and the Cuzick’s test for trend was carried out [17]. 
The effect of each of the 27 variables on the odds of DO was estimated both by univariate 
analysis and adjusted analysis using logistic regression. Assuming a bladder diary completion 
rate of 75% and a DO prevalence of 36% in our population [18] we estimated a minimum 
sample size of 1000 patients based on the work by Peduzzi et al (N = 10 k / p, where k equals 
the number of covariates and p the smallest of the proportions of negative or positive cases in the 
population) [19].  
An investigator-led best model selection approach was used to select the best predictors of 
DO in the multiple logistic regression model, as opposed to machine-led step-wise regression, 
which is not advisable. For ordinal explanatory variables, Mantal-Haenszel odds ratio for 
trend was used to estimate the odds ratio taking account of the ordinal nature of the data [20]. 
To deal with missing data in the adjusted model, we explored complete case analysis but also 
used multiple imputation methods [21,22]. We carried out 20 multiple imputations and 
estimated the best predictors of DO. We used estimates from the adjusted model after 
multiple imputations to create the prediction scoring tool. To test how the prediction tool 
agreed with the observed values, Kappa statistics was calculated. The overall predictive 
ability for our prediction model was measured by the area under the Receiver Operating 
Characteristic (ROC) curve. Sensitivity, specificity and likelihood ratio for each cut-off point 
of the scoring system were calculated. All analyses were performed using STATA software, 
version 12.1 SE (Stata Corporation, College Station, TX, USA).  
 
Results 
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1006 women with LUTS were included in the study. The mean age was 51.4 years (SD: 14.8) 
and 52 % of them were postmenopausal. 374 patients (37%) were diagnosed with DO. The 
basic characteristics of our population with the univariate comparison are presented in table 
1. 
As a result of the multiple logistic regression with multiple imputations the investigating 
team determined that the factors considered best predictors of DO were UUI, urge rating/void 
and parity. The absence of SUI, no vaginal bulging and no history of previous continence 
surgery were also good predictors of DO (table 2). 
Using estimates from the adjusted model and the relevant odds ratios (table 2), we developed 
a prediction model called King’s DO Score (KiDOS). The scoring system is such that for 
those that had decreased effect in DO, a negative score was given, for those with an increased 
effect, a positive score was given with respect to odds ratio. In KiDOS, presence of UUI 
scores 5; mean urge rating/void ≥ 3 scores 3; parity ≥ 2 scores 2; history of previous 
continence surgery scores -1; presence of SUI scores -1; and the complaint of vaginal bulging 
scores -1 (table 3). If a criterion is absent, then the score is 0 and the total score can vary from 
a value of -3 to +10.   
The overall predictive ability for our prediction model, measured by the area under the 
Receiver Operating Characteristic (ROC) curve was 0.748 (95%CI 0.741, 0.755) (figure 1). 
The agreement between the predicted and the observed values was found to be kappa=0.685 
(95% CI 0.597, 0.721).  
The overall sensitivity, specificity and likelihood ratio for each cut-off point are shown in 
table 4. The statistical optimal cut-off point for our score was 6 (table 5), achieving a 
sensitivity of 62.4% (95%CI 61.3%, 63.6%), a specificity of 72.2% (95%CI 71.4%, 73.0%), a 
positive predictive value of 57.9% (95% CI 56.7%, 59.0%) and a negative predictive value of 
75.9% (96% CI 75.0%, 76.7%). In comparison, in our cohort the symptom of urgency had a 
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sensitivity of 96.2% and a specificity of 28.1% to predict DO and urgency incontinence a 
sensitivity of 88.2% and a specificity of 47.6% (table 6). 
 
Comment 
As the routine use of UDS is currently discouraged, alternative methods have been explored 
in order to improve the clinical prediction of DO. This study describes the development of a 
prediction model with an associated scoring system for DO (KiDOS). This model, combining 
symptoms, medical history and non-invasive tests, is able to predict DO more accurately than 
a symptomatic diagnosis alone, in women with LUTS. 
The KiDOS is an easily calculated scoring system that includes six variables obtained during 
a standard assessment of LUTS. The predictors can be established with history taking (parity, 
previous continence surgery) and completion of a validated symptom questionnaire (UUI, 
SUI, vaginal bulging) and a bladder diary (urge rating/void). Our prediction model was 
developed using a large sample with a prior power calculation and following robust statistical 
methods. The diagnostic accuracy of our prediction model based on the ROC analysis will be 
classified as “fair” (0.7-0.8) with an area under the ROC curve of 0.748. The value of Kappa 
statistics (0.685) correspond to “good” agreement between the predicted values and the 
observed urodynamic findings [23]. Based on the performance of the prediction model we 
could argue that it can improve symptomatic diagnosis but cannot replace UDS altogether. 
A number of authors have attempted to correlate symptoms, examination findings and 
frequency-volume variables with a urodynamic diagnosis of DO [10,11,24,25,26]. Contreras 
Ortiz et al described the Bladder Instability Discriminant Index (BIDI), a clinical index 
derived by 7-day frequency-volume charts from only 89 patients [10]. Despite a reported 
sensitivity of 82% and specificity of 87% its use in clinical practice has been limited due to 
the required complex calculations. Some of these variables (daytime / nighttime voids and 
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functional capacity) were included as potential predictors in our analysis. In the univariate 
comparison, nighttime voids (p=0.001) and functional capacity (p<0.001) but no daytime 
voids (p=0.143) were statistically significant. However, their potential contribution to the 
model following the adjusted analysis with logistic regression was limited and therefore not 
included. In our study the bladder diary included the validated PPIUS and the strongest 
predictor was mean urge rating/void. This finding reinforces the current knowledge that 
urinary urgency, rather than nocturia or daytime frequency, is the defining and cornerstone 
symptom of OAB and DO [27]. 
Regarding LUTS it has been shown that responses to self-completed postal questionnaires 
have a better relationship with urodynamic findings compared to interview-assisted 
questionnaire responses [24]. Matharu et al also assessed the relationship between LUTS 
reported in a self-completed questionnaire and urodynamic diagnosis [25]. In their 
multivariate model for DO they included UUI, strength of urgency, and nocturia as positive 
predictors and SUI as a negative predictor. Their risk model had a sensitivity of 63% and a 
specificity of 65%, but the results of a ROC analysis were not presented. In line with this 
study we found that UUI was the strongest positive predictor (aOR 4.10) and SUI the 
strongest negative symptom predictor (aOR 0.45) for DO. In our study the subjective strength 
of urgency and symptom of nocturia were expressed as objectively measured urge rating/void 
and nighttime voids on the bladder diary.  
A study of 171 women by Vella et al attempted to develop a scoring system combining 
demographic data, LUTS and frequency-volume chart data [11]. The nine variables (with the 
contributing score) included in the final questionnaire were: urgency (11), voided volume < 
300ml (9), UUI (8), nocturia (6), nocturnal enuresis (6), flooding (6), nulliparity (5), 
frequency (2), non-caucasian ethnicity (2). In view of the use of multiple variables in a small 
sample without adjusted logistic regression analysis, there is a significant risk of overfitting 
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for this scoring system. In our model parity ≥ 2 rather than nulliparity was a predictor of DO 
and our findings are consistent with epidemiological research relating to OAB [28]. 
A recent study, published after the international presentation of our study, used a similar 
design in a cohort of 1140 women [26]. In their final logistic model they included UUI, 
urgency and nocturia as positive predictors and SUI, parity ≥ 2 and signs of prolapse as 
negative predictors. This model had a sensitivity of 0.61, a specificity of 0.73 and an area 
under the ROC curve of 0.737. This large study, excluding the contradicting results about 
parity, enforces the validity of our findings in a different population sample. However, as this 
study did not develop a scoring system and did not report a logistic regression equation, its 
clinical value is limited. The difference in the statistical methods has probably led the authors 
of that study to consider their findings not clinically useful. Regarding the addition of POP as 
a negative predictor (symptom of vaginal bulging in the current study, sign of POP in the 
study by Haylen et al) we can postulate that POP could induce the “irritative” symptoms of 
urinary urgency, without inducing the pathophysiological mechanism of DO. Similar to this 
mechanism post-operative formation of scar tissue and localised denervation after continence 
surgery could explain the performance of prior continence surgery as negative predictor.    
The idea behind the scoring system is to balance the scores and as such, the higher the score, 
the more likely the model indicates that someone has DO. The proposed cut-off point for 
KiDOS is 6, because this cut-off balances out the sensitivity and specificity and achieves 
reasonable PPV and NPV. Using the KiDOS as a screening tool at the initial assessment of 
all women with LUTS could help physicians to arrange conservative and drug therapy 
appropriately. For women with score of 5 or less, supervised pelvic floor muscle training and 
bladder retraining for 3 months might be offered before consideration of drug therapy (figure 
2). However, depending on the setting and the use of the model in a management algorithm, 
different cut-offs could be selected in order to optimise sensitivity or specificity. If KiDOS is 
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used to reduce the need for UDS after failed conservative therapy prior to stress incontinence 
surgery, we would consider a cut-off of 4 in order to increase the detection of DO pre-
operatively.  
Another approach in order to reduce the need for invasive urodynamics is the use of 
biomarkers as predictors of DO. Despite the initial promising results [29], a recent multi-
centre study of 687 women assessing the diagnostic accuracy of BWT failed to reproduce 
similar findings with a reported sensitivity of 42%, specificity of 62% for BWT >5mm and 
an area under the ROC curve of 0.53 [30]. Near infrared spectroscopy has also been shown to 
be an unreliable method for detecting DO in women with OAB symptoms [31]. While several 
small studies have demonstrated a trend towards higher urinary nerve growth factor (NGF) in 
patients with DO, a recent systematic review of the literature has stated that the data are 
imprecise and hence NGF cannot be recommended for use in current clinical practice [32]. 
Compared to these biomarkers, our feasible prediction model combines an overall superior 
diagnostic accuracy with minimal cost as opposed to UDS which are considered to be 
expensive and invasive.            
We acknowledge that our study had some limitations, the first being the lack of external 
validation of our prediction model. While our large sample and our robust statistical methods 
have reduced the risk of overfitting, external validation is required before introduction of the 
model into clinical practice. The clinical role of the model will remain questionable until 
external validation studies demonstrate its value. Another limitation of the study is the 
missing data of the bladder diary variables. The impact of those data on our calculations was 
regulated by multiple imputations. The routine use of urgency scales in clinical practice 
might decrease patient compliance in bladder diary completion and hence calculations of urge 
rating / void may lack accuracy. Finally, as this is a single-centre study in a tertiary referral 
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unit the results may not be generalised for all women with LUTS or for centres that perform 
urodynamics following different protocols. 
Diagnostic prediction models can help decision making and reduce the need for expensive 
investigations. Their adoption in other fields of obstetrics and gynaecology such as 
gynaecological oncology [33] highlights the need for similar development in 
urogynaecology. Sophisticated powerful instruments such as artificial neural networks might 
further improve the performance of risk assessment tools [34]. However, we must appreciate 
the fact that DO is a multifactorial condition and thus no model may be sufficiently selective 
and sensitive [35].  
In conclusion, this model is able to predict DO more accurately than a symptomatic diagnosis 
alone in women with LUTS. The introduction of this easily calculated scoring system as a 
screening tool into clinical practice may reduce the need for expensive and invasive tests to 
diagnose DO, but cannot replace UDS completely. 
 
Legends 
Figure 1: Receiver Operating Characteristic (ROC) analysis 
Figure 2: Proposed algorithm for management of women with lower urinary tract symptoms 
(LUTS) 
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Table 1 Basic characteristics of the population: Univariate comparison 
 Detrusor 
overactivity 
  
Covariate Yes, n=374 (37.2%) No, n=632 (62.8%) p-value 
Age, mean (SD) 52.1 (15.8) 51.1 (14.3) 0.284a 
BMI (kgm
-2
), 
median (IQR) 
28.0 (24.0, 33.0) 26.0 (23.0, 30.0) <0.001
b 
Parity, mean (SD) 2.37 (1.64) 2.02 (1.39) <0.001a 
Racial group, n (%)   <0.001c 
White 165 (53.9%) 419 (75.2%)  
Black 110 (34.0%) 78 (14.0%)  
Asian 10 (3.27%) 23 (4.13%)  
Mixed 3 (0.98%) 8 (1.44%)  
Other 18 (5.9%) 29 (5.21%)  
Menopause, yes, n 
(%) 
194 (51.9%) 328 (51.9%) 0.993c 
Hormone 
replacement 
therapy, n (%) 
  0.039c 
No 350 (93.6%) 564 (89.2%)  
Local oestrogens 9 (2.41%) 35 (5.54%)  
Systemic HRTs 15 (4.01%) 33 (5.22%)  
Hysterectomy, yes, 
n (%) 
80 (21.4%) 167 (26.4%) 0.073c 
Prolapse surgery, 
yes, n (%) 
31 (8.29%) 93 (14.7%) 0.003c 
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Continence surgery, 
yes, n (%) 
36 (9.63%) 104 (16.5%) 0.002
c 
Stress incontinence, 
yes, n (%) 
245 (65.5%) 404 (63.9%) 0.612
c 
Urinary urgency, 
yes, n (%) 
360 (96.3%) 454 (71.8%) <0.001
c 
Urgency urinary 
incontinence, yes, n 
(%) 
330 (88.2%) 331 (52.4%) <0.001
c 
Vaginal bulging, 
yes, n (%) 
65 (17.4%) 155 (24.5%) 0.008c 
Bladder pain, yes, n 
(%) 
8 (2.14%) 21 (3.32%) 0.278c 
Recurrent UTIs, 
yes, n (%) 
49 (13.1%) 102 (16.1%) 0.192c 
Voiding difficulties, 
yes, n (%) 
53 (14.2%) 106 (16.8%) 0.274
c 
Continuous 
incontinence, yes, n 
(%)  
4 (1.07%) 3 (0.47%) 0.434
d 
Nocturnal enuresis, 
yes, n (%) 
24 (6.42%) 9 (1.42) <0.001
c 
Day time voids, 
median (IQR) 
8.00 (6.00, 10.0) 8.00 (6.00, 9.00) 0.143b 
Night time voids 
median (IQR) 
1.00 (0, 2.00) 1.00 (0, 1.00) 0.001
b 
Functional capacity, 
mean (SD)  
379.1 (150.5) 470.0 (191.0) <0.001a 
Max PPIUSS, n (%)   <0.001e 
0 0 (0.00%) 4 (1.47%)  
1 1 (0.7%) 17 (6.25%)  
2 12 (8.63%) 62 (22.8%)  
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3 21 (15.1%) 102 (37.5%)  
4 105 (75.5%) 87 (32.0%)  
Mean urge 
rating/void, mean 
(SD) 
2.53 (0.67) 1.81 (0.73) <0.001
a 
Daily urgency 
episodes, median 
(IQR) 
4.66 (2.67, 6.66) 1.33 (0.00, 3.66) <0.001b 
Voided volume 
(mls), median (IQR) 
127.0 (70.0, 249.0) 178.5 (93.0, 346.0) <0.001
b 
Peak flow rate 
(ml/sec), median 
(IQR) 
18.0 (12.0, 29.0) 20.0 (12.0, 29.0) 0.455
b 
POPQ ordinal stage, 
n (%) 
  0.787
e 
1 244 (66.0%) 411 (65.7%)  
2 105 (28.4%) 169 (27.0%)  
3 21 (5.68%) 45 (7.2%)  
4 0 (0%) 1 (0.16%)  
 
 
BMI: body mass index, HRT: hormone replacement therapy, IQR: interquartile range, POPQ: 
pelvic organ prolapse quantification system, PPIUS: patient’s perception of intensity of 
urgency scale, SD: standard deviation, UTI: urinary tract infection 
a
 Two-sample t test (unequal variance) 
b 
Two-sample Wilcoxon rank sum test (Mann-Whitney test) 
c 
Chi squared test 
d Fisher’s exact test 
e Cuzick’s non-parametric test for trend 
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Table 2 Best predictors following multiple logistic regression with multiple imputations 
 
 
Covariate Adjusted odds ratio 
(95% confidence intervals) 
p-value 
Urgency urinary incontinence 4.10 (2.61, 6.48) <0.001 
Urge rating / void 2.82 (1.99, 4.00) <0.001 
Parity 1.21 (1.08, 1.36) 0.001 
Continence surgery 0.38 (0.23, 0.65) <0.001 
Stress urinary incontinence 0.45 (0.31, 0.66) <0.001 
Vaginal bulging 0.57 (0.38, 0.85) 0.006 
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Table 3 King’s Detrusor Overactivity Score (KiDOS) 
 
 
 
 Yes No 
Urgency urinary incontinence 5 0 
Urge rating / void ≥ 3 3 0 
Parity ≥ 2 2 0 
Continence surgery -1 0 
Stress urinary incontinence -1 0 
Vaginal bulging -1 0 
Total score (range) (-3, +10) 
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Table 4  Overall sensitivity, specificity and likelihood ratio for each KiDOS cut-off point 
 
Cut-point Sensitivity Specificity Correctly 
classified 
LR+ LR- d_OR 
≥ -2 100.00% 0.00% 37.95% 1.000 - - 
≥ -1 100.00% 1.66% 38.98% 1.016 0.000   
≥ 0 99.72% 8.10% 42.87% 1.085 0.035 31.0 
≥ 1 95.10% 24.18% 51.09% 1.254 0.203 6.18 
≥ 2 91.37% 42.05% 60.76% 1.577 0.205 7.69 
≥ 3 89.04% 46.94% 62.92% 1.678 0.234 7.17 
≥ 4 87.75% 49.15% 63.79% 1.726 0.249 6.93 
≥ 5 78.51% 59.33% 66.61% 1.930 0.362 5.33 
≥ 6 62.43% 72.21% 68.50% 2.247 0.520 4.32 
≥ 7 33.71% 89.38% 68.26% 3.175 0.742 4.28 
≥ 8 23.42% 94.68% 67.64% 4.401 0.809 5.44 
≥ 9 15.34% 97.11% 66.08% 5.312 0.872 6.09 
≥ 10 2.61% 99.65% 62.83% 7.574 0.977 7.75 
> 10 0.00% 100.00% 62.05% - 1.000 - 
       LR Likelihood ratio ve Pr ve ve / Pr ve ve        , 
       LR Likelihood ratio ve Pr ve ve / Pr ve ve        , 
d-OR diagnostic odds ratio LR( ) / LR( )     
=Undefined 
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Table 5 Sensitivity, specificity, positive and negative predictive value for KiDOS cut-off of ≥6 
 
 
 Estimate (95% confidence intervals) 
Sensitivity 62.4% (61.3%, 63.6%) 
Specificity 72.2% (71.4%, 73.0%) 
Area under ROC curve 0.673 (0.666, 0.680) 
Positive predictive value (PPV) 57.9% (56.7%, 59.0%) 
Negative predictive value (NPV) 75.9% (75.0%, 76.7%) 
 
ROC: receiver operating characteristic 
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Table 6 Sensitivity, specificity, positive and negative predictive value for urgency and 
urgency incontinence 
 
 
 
 Urgency Urgency urinary  incontinence 
Sensitivity 96.2% 88.2% 
Specificity 28.1% 47.6% 
Positive predictive value (PPV) 44.2% 49.9% 
Negative predictive value (NPV) 92.7% 87.2% 
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